The weight loss pill had a strong U.S. launch this year, and Novo believes that will be replicated in other markets around the world. For the full story, visit the source.
Business
Novo Nordisk’s next obesity battlefront: Winning beyond America
The weight loss pill had a strong U.S. launch this year, and Novo believes that will be replicated in other markets around the world.
By Elsa Ohlen· CNBC· 1 day ago· 2 min read
This summary is sourced from CNBC. Read the full article at:CNBC